The Laryngoscope · 1987 · 27 citations · 9 references
MedicineClinical SciencesPediatricsNeonatologyPediatric PulmonologyPulmonologyNasal ObstructionNeonatal Respiratory DisordersRespiratory DiseaseRespiratory Distress In NewbornsRespiratory Distress SyndromeRespiratory MedicineNasal TurbinatesNeonatal Nasal ObstructionNeonatal Respiratory Distress SyndromePediatric RhinitisPhenylephrine AdministrationPhenylephrine TherapyRhinitis MedicamentosaVasoconstrictor Therapy
Rhinitis medicamentosa from topical vasoconstrictor abuse results in nasal obstruction which can be life-threatening in neonates. Neonates are obligate nasal breathers, most learning oral respiration by 2 months of age. A neonate was started on topical phenylephrine at birth, and by 3 weeks of age was having multiple daily episodes of apnea and cyanosis. An evaluation documented edematous, obstructing nasal turbinates, as well as polycythemia, cardiomegaly, and prominence of the pulmonary vasculature. A nasopharyngeal airway alleviated the obstruction until the turbinates recovered, and the other abnormalities quickly resolved.
9
Robert J. Toohill, Roger H. Lehman, Thomas W. Grossman et al. · The Laryngoscope · 1981 · 78 citations
Treatment with xylometazoline (Otrivin) nosedrops over a six-week period.
Björn Petruson · PubMed · 1981 · 35 citations
Samy Elwany, Wahid M. Stephanos · ORL · 2010 · 34 citations
Richard L. Mabry · Southern Medical Journal · 1982 · 26 citations